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ABSTRACT
Proper expression of the genes of the human β-globin
gene locus requires the associated locus control
region (LCR). Structurally, the LCR is defined by the
presence of four domains of erythroid-specific
chromatin structure. These domains, which have been
characterized as DNase I hypersensitive sites (HSs),
comprise the active elements of the LCR. The major
focus of this research is to define the cis-acting
elements which are required for the formation of these
domains of unique chromatin structure. Our previous
investigations on the formation of LCR HS4 demonstrated that NF-E2 and tandem, inverted GATA binding
sites are required for the formation of the native HS.
Similarly arranged NF-E2 and tandem GATA sites are
present within the core regions of the other human
LCR HSs and are evolutionarily conserved. Using
site-directed mutagenesis of human HSs 2 and 3 we
have tested the hypothesis that these NF-E2 and GATA
sites are common requirements for the formation of all
LCR HSs. We find that mutation of these elements, and
particularly the GATA elements, results in a decrease
or complete loss of DNase I hypersensitivity. These data
imply the presence of common structural elements
within the core of each LCR HS which are required for
erythroid-specific chromatin structure reorganization.
INTRODUCTION
The human β-globin gene locus contains five expressed globin
genes (Fig. 1). These genes are expressed only in cells of the
erythroid lineage and are regulated in a developmentally specific
pattern (1). This complex pattern of gene expression makes the
human β-globin locus a model for studying the regulation of
complex multi-gene loci. In particular, the β-globin gene locus
has served as an important model for studies investigating the
interaction between chromatin structure and gene expression in
higher eukaryotic organisms. In erythroid cells, the chromatin

structure of the human β-globin gene locus undergoes a dramatic
reorganization. These changes are most often demonstrated as
alterations in the nuclease sensitivity of the locus (Fig. 1). In
erythroid cells, the entire locus becomes more sensitive to DNase I
digestion (2,3). A second change involves the formation of
DNase I hypersensitive sites (HSs) in association with the
promoters of actively transcribed β-globin genes (4). A third type
of erythroid-specific chromatin structure is the DNase I ‘super’
or ‘major’ HS. These HSs flank the globin structural genes (5–7).
5′ HSs 1–4 comprise the β-globin locus control region (LCR)
(Fig. 1; 8,9).
Several lines of evidence indicate a link between the chromatin
structure of the human β-globin gene locus and human β-globin
gene regulation. These studies also suggest that the β-globin LCR
is the primary determinant of locus chromatin structure. For
example, natural deletion mutations of the LCR result in complete
silencing of structurally intact β-globin genes (2,10). This effect
is demonstrated by the Hispanic γδβ-thalassemia mutation, in
which LCR HSs 2, 3 and 4 are deleted but all of the globin genes
are intact (11). Not only are none of the genes expressed, but none
of the characteristic erythroid-specific chromatin structures of the
locus are formed (3). Neither the remaining LCR HS (HS1) nor
the promoter HSs are formed (3). Similarly, insertion of a
hygromycin resistance gene between HS1 and HS2 of the human
LCR in a mouse/human hybrid cell line resulted in silencing of
globin gene expression and inhibition of HS formation downstream of the inserted gene (12). These results suggest that a
primary function of the LCR is to establish an active chromatin
structure throughout the locus. A second link between LCR
function and β-globin locus chromatin structure involves the
ability of the LCR to direct position-independent expression of
linked globin genes in transgenic mice. This ability appears to be
due to the capacity of the LCR to form a normal, active chromatin
structure irrespective of the location at which the transgene is
incorporated into the host genome (13).
The formation of the LCR HSs is also likely to be important for
the proper functioning of the LCR. These domains of locally altered
chromatin structure are unique in that they are erythroid-specific,
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developmentally stable (5,6) and ∼10- to 20-fold more sensitive
to DNase I than the promoter-associated HSs (5,7,14). Perhaps
most significant is the finding that the HSs are coincident with the
functionally active core elements of the LCR (15–17). Similar
results have been found for the chicken β-globin 3′ enhancer,
which is also able to confer position-independent expression in
transgenic mice (18–20). As with most DNase I HSs, the
erythroid-specific reorganization of local chromatin structure
associated with the LCR HSs appears to be due to the disruption
or displacement of nucleosomes (14,21). In other systems,
similar changes have been shown to be necessary for the binding
of the full complement of trans-acting factors to a specific
cis-acting element (22).
As a step in understanding how the complex reorganization of
β-globin locus chromatin structure occurs we have focused on the
mechanisms by which the LCR HSs are formed. In our initial
experiments we used human HS4 as a model for studying this
process. We demonstrated that a 1.3 kb fragment from the region
of HS4 is able to direct the formation of HS4 in an erythroid-specific
manner in transgenic mice (23). Subsequent truncation and
deletion experiments indicated that an ∼100 bp element near the
center of HS4 is both necessary and sufficient for the formation
of the HS (23). We have termed this element the HS-forming
element or HSFE. Further analysis revealed that an NF-E2
binding site and tandem, inverted GATA sites are required for the
formation of the native chromatin structure of HS4 (14). These
binding sites are separated by ∼50 bp. The finding that NF-E2 and
GATA binding sites are required for LCR HS formation provided
at least a partial basis for the erythroid specificity of these HSs.
Examination of the DNA sequences of other LCR HS core
regions revealed that similar NF-E2 and tandem, inverted GATA
binding sites, also separated by ∼50 bp, were found within the
core region of each human LCR HS (14). These binding sites are
evolutionarily conserved in the LCR HSs of chickens, rabbits,
goats and mice (14,24).
On the basis of these findings, we hypothesized that the NF-E2
and tandem, inverted GATA binding sites found in each of the
human LCR HS cores are necessary for the formation of each of
these domains of erythroid-specific chromatin structure. If true,
this would be consistent with a common underlying chromatin
structure for each of the LCR HSs and would support a common
mechanism of formation of the individual HSs. To test this
hypothesis we have performed site-directed mutagenesis of the
NF-E2 and tandem, inverted GATA sites found within the core
regions of human β-globin LCR HSs 2 and 3. These elements
were then stably transfected into MEL cells and pools of clones
evaluated for the ability of the mutant HSs to form. Using
micrococcal nuclease (MNase) we also performed a comparative
analysis of the nucleosomal structures of the HSs.
MATERIALS AND METHODS
HS2 and HS3 mutant constructs
HS2 (1.45 kb, KpnI–BglII), HS3 (1.9 kb, HindIII–HindIII) and
HS4 (1.4 kb, BamHI–SphI) fragments were subcloned into a
previously described pUC-based plasmid containing a neomycin
resistance gene (Fig. 1B; 23). Sequences of the HS fragments can
be found at GenBank accession no. J00179, which contains the
human β-globin gene locus. Mutations of HS2 were made within
the p∆HS2 plasmid. HS3 and the neoR gene serve as positive,
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internal controls for HS formation in this construct. Mutations of
HS3 were made within the p∆HS3 plasmid, where HS4 and the
neoR gene serve as positive, internal controls (Fig. 1B). Sitedirected mutagenesis of individual NF-E2 and GATA binding
motifs was performed using the Chameleon method (Stratagene,
La Jolla, CA). Oligonucleotides used in the mutagenesis procedure
contained the mutated sequences shown in Figure 2 and ranged in
size from 38 to 51 bp. Multiple rounds of mutagenesis were
performed to obtain constructs with multiple binding site
mutations. Test constructs were stably transfected into mouse
erythroleukemia (MEL) cells and pools of 25 clones selected in
G418 as previously described (23).
Nuclease sensitivity assays
In vivo DNase I sensitivity assays were performed on nuclei
isolated from pools of stable transfectants as previously described
(14,23). For most experiments nuclei (200 µg DNA/reaction)
were digested in a volume of 200 µl with DNase I at concentrations
of 0, 0.1, 0.25, 0.5, 0.75, 1.0, 2.0, 3.0 and 4.0 µg/ml. In some
experiments the higher DNase I concentrations are not shown due
to complete DNA digestion. Reactions were performed at 37C
for 10 min. Following DNase I treatment, genomic DNA was
isolated and digested to completion with XhoI/SalI for Southern
blots of HS2 mutants and XhoI for Southern blots of HS3 (Fig. 1).
For experiments focusing on individual HSs within the constructs
XhoI/BglII (HS2) or HindIII (HS3) were used for Southern
blotting (Fig. 1). The following probes were used for indirect
end-labeling in Southern blot experiments (Figs 1 and 6): HS4,
634 bp SacI–SacI fragment from the 5′-end of HS4 fragment;
HS3, 259 bp HindIII–SacI fragment from the 5′-end of the HS3
fragment; HS2, 318 bp KpnI–SacI fragment from the 5′-end of
the HS2 fragment. In vivo MNase assays of nucleosome
positioning were performed as previously described (14).
Regions of DNase I sensitivity and nucleosome position were
mapped by plotting the migration distance of the molecular
weight markers versus the logarithm of their size in base pairs.
These data points were then fitted to the equation
fragment size (bp) = m[e i(migration distance in cm)].
This produced a straight line where m is the slope of the line and
i is the y-intercept. Correlation coefficients for the plots were
>0.99. By measuring the migration distances of the upper and
lower limits of each DNase I HS or MNase cutting site and
applying the above formula the size, and therefore location, of
each HS within the parental fragment was determined.
RESULTS
To test our hypothesis that the NF-E2 and tandem, inverted GATA
binding sites of each β-globin LCR HS are necessary for the
formation of the associated domains of altered chromatin
structure, we performed a mutational analysis of human LCR HSs
2 and 3. To do this we constructed plasmids containing the wild-type
HS sequences. Each plasmid also contained a second wild-type HS,
either HS4 or HS3, to serve as an internal control for LCR HS
formation and a neoR gene for the selection of stable clones (Fig. 1).
The enhancer–promoter region of the neoR gene also forms a strong
DNase I HS and serves as a second internal control. This region
contains a tandem repeat of a polyoma virus enhancer and the herpes
simplex thymidine kinase promoter (25). These constructs, their
associated regions of DNase I hypersensitivity and restriction
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of these experiments are shown in Figure 3. Analysis of the
wild-type construct (H2WT) demonstrates several DNase I HSs.
These include the intense HS associated with the neoR gene, the
primary (1) and secondary (2) HS3 sites and, near the bottom
of the blot, HS2. Wild-type HS2 is of approximately the same
sensitivity as 1 HS3 and the neoR HS and is typical of the ‘super’
HSs of the LCR. 2 HS3 is much less sensitive to DNase I
requiring 10- to 20-fold more enzyme to achieve cutting equal to
1 HS3 (14). These two levels of DNase I sensitivity allow for
semi-quantitative determination of the DNase I sensitivity of
mutant HSs.
Mutation of the tandem NF-E2 binding sites within the HS2
core (mutant H2M1) produces a decrease in the sensitivity of the
HS2 region to DNase I. The intensity of HS2 is now approximately
equivalent to that of 2 HS3. These results are similar to what we
observed in our original mutational studies of HS4, where
mutation of the NF-E2 binding motif also resulted in a decrease
in the sensitivity of HS4 (14). Mutation of the tandem, inverted
GATA sites (H2M2) also results in a decreased sensitivity of HS2.
These findings are also similar to our previous results for HS4.
Mutation of both the NF-E2 and GATA sites (H2M3) results in
the complete loss of HS2. This is despite the fact that all other
factor binding sites in the region of the HS2 core remain intact.
These results recapitulate our findings for HS4 and support the
hypothesis that the NF-E2 and GATA binding sites are critical for
the formation of both HS2 and HS4.
Figure 1. (A) Chromatin structure of the human β-globin gene locus. The five
expressed β-globin genes are shown. The horizontal arrow represents the
tissue-specific nuclease sensitivity observed throughout the entire locus in
erythroid cells. Small vertical arrows represent DNase I HSs associated with the
promoters of the globin genes. Boxes represent the 5′ DNase I ‘super’ HSs.
5′ HSs 1–4 are erythroid-specific, developmentally stable and comprise the
β-globin locus control region (LCR). (B) Plasmid-based constructs used to
determine the cis-acting sequences necessary for HS2 and HS3 formation.
Mutations of HS2 and HS3 were made within the p∆HS2 and p∆HS3 plasmids.
Approximate locations of HSs are indicated by hatched boxes. Probes and
restriction enzyme sites used in DNase I sensitivity assays are shown. X, XhoI;
H, HindIII; S, SalI; B, BglII.

enzyme sites are shown in Figure 1. When stably transfected into
MEL cells, plasmids containing the LCR HS fragments are able
to direct formation of their associated DNase I HSs (23,26). As
shown in Figure 2, site-directed mutagenesis was used to
completely eliminate the NF-E2 and tandem GATA binding sites
in individual constructs. Individual constructs were then transfected
into MEL cells. Pools of 25 neomycin-resistant clones were
selected and analyzed for the ability of the mutant constructs to
form their associated DNase I HS.
Mutational analysis of LCR HS2
β-Globin LCR HS2 is unique in that it contains a strong
erythroid-specific enhancer (27,28). This enhancer function is
mediated through tandem NF-E2 binding sites located within the
active core of the element (29). Besides NF-E2, the binding sites
are also able to bind the transcription factor AP-1 and NF-E2-related
factors LCR-F1 and NRF2 (28,30,31). The tandem NF-E2 sites
are located ∼50 bp 5′ of tandem, inverted GATA binding motifs.
Together they comprise the region homologous to the HS4 HSFE
(14). To assess the role of the tandem NF-E2 sites and tandem,
inverted GATA sites in LCR HS2 formation we performed
site-directed mutagenesis of these binding elements. The results

Mutational analysis of LCR HS3
Experiments analyzing the role of NF-E2 and GATA binding sites
in HS3 formation are shown in Figure 4. While HS3 does not
possess the enhancer activity of HS2, it has been recently shown
to have the unique ability to confer position-independent
expression on linked genes in single copy transgenic mice (32).
Structurally, 1 HS3 is also unique in that it is comprised of an
intense HS typical of the LCR super HSs and an immediately
adjacent HS which is much less intense (Fig. 4, H3WT). Also
unique to HS3 is the presence of two sets of tandem, inverted
GATA sites. These are located ∼50 bp 3′ of the NF-E2 site and
also ∼110 bp 3′ of the site (Fig. 2).
Analysis of the HS3 wild-type construct again shows several
HSs. These include the neoR-associated HS, the two HS3 sites
and the internal control for these experiments, HS4. Note that in
the wild-type construct the intensity of 1 HS3 is approximately
equal to that of the neoR HS. Mutation of the NF-E2 binding site
(H3M1) results in a minor decrease in the intensity of 1 HS3
when compared with the neoR internal control. The next panel
(H3M2) shows that mutation of the proximal GATA sites has little
effect on HS3 formation. However, when the distal GATA sites
are mutated (H3M3), the intensity of 1 HS3 is dramatically
reduced to less than the level of 2 HS3. 2 HS3 is unaffected by
any of these mutations.
In Figure 5 the effect of mutating multiple binding sites within
the 1 HS3 core region is shown. Mutation of the NF-E2 and
proximal GATA sites (H3M4) causes the intensity of the site to
be minimally decreased. Mutation of both the NF-E2 and distal
GATA sites (H3M5) results in a marked decrease in the sensitivity
of 1 HS3 such that it is now less intensive than 2 HS3. Finally,
mutating both GATA sites (H3M6) or both GATA sites and the
NF-E2 site (H3M7) results in the complete loss of 1 HS3. The HS4
internal control HS is obscured in these experiments due to the
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Figure 2. Mutations used to evaluate the roles of NF-E2 and GATA binding elements in HS2 and HS3 formation. Mutations were introduced into plasmids p∆HS2
and p∆HS3 by site-directed mutagenesis. HS2 contains tandem NF-E2 sites and tandem, inverted GATA binding sites. HS3 contains two sets of tandem, inverted GATA
binding sites located ∼50 and ∼110 bp 5′ of the NF-E2 site.

presence of an artifactual band. This band is present in the ‘0’
DNase I lane and does not change with increasing DNase I
concentration. As with the single mutations, 2 HS3 does not
appear to be effected by any of the combined mutations. These
results indicate that, just as for HS4 and HS2, NF-E2 and tandem,
inverted GATA sites are necessary for the formation of 1 HS3.
The distal tandem GATA sites appear to be more important for
HS3 formation than the proximal GATA sites.
Local chromatin structure of HS2 and HS3
The finding of conserved NF-E2 and GATA elements which are
required for local chromatin reorganization within each LCR HS
suggests that there may also be a common underlying structure
within each HS region. To investigate this possibility we next
examined the nucleosomal structure of HS2 and HS3. These
experiments utilized DNase I, which preferentially digests
nuclear DNA in regions of disrupted or displaced nucleosomes,
and micrococcal nuclease (MNase), which preferentially cuts
linker DNA between nucleosomes, as probes of local chromatin
structure (21). Using these techniques the locations of specific
regions of nuclease hypersensitivity and the positions of individual
nucleosomes can be determined. Our previous mapping studies
of LCR HS4 demonstrated that this HS is composed of an intense
central band of DNase I sensitivity covering ∼200 bp (14,23).
This central area of sensitivity is flanked by less intense DNase I
HS bands. MNase analysis of HS4 demonstrated that in erythroid
cells a single nucleosome was disrupted or displaced from the central
region of the DNase I HS and that nucleosomes formed a positioned
array spanning several hundred base pairs (14). The HS4 HSFE is
located near the 5′ boundary of the region of open chromatin which
closely corresponds to the functional core of HS4 when analyzed for
its ability to direct copy number-dependent expression in transgenic

mice (15). To determine whether the local chromatin structures
of HS2 and HS3 are similarly organized, we performed DNase I
and MNase mapping experiments on these two HSs. The results
of these experiments are shown in Figure 6.
Results for HS2 show that, similar to HS4, a broad intense
central band is formed with DNase digestion (Fig. 6A). Flanking
bands of lesser intensity are also seen, indicating that chromatin
structure is altered over several hundred base pairs. These HSs are
indicated by brackets and also shown schematically. Mapping the
boundaries of the central domain of DNase I hypersensitivity
reveals an ∼270 bp region of open chromatin structure. Nucleosomal
mapping studies using MNase indicate nucleosomal disruption or
displacement directly over the central core region of HS2. This is
best seen at the highest MNase concentration, where a broadening
of the band which overlies the DNase I HS occurs. The region of
maximal MNase digestion is, however, located one internucleosomal space 5′ of the maximal DNase I cutting site. These results
are summarized schematically. This analysis indicates that HS2
is structurally similar to LCR HS4 at the nucleosomal level by
several criteria. In both HSs a single area of intense DNase I
sensitivity is flanked by areas of less intense sensitivity. The
central band of both HSs corresponds to the apparent disruption
or displacement of a single nucleosome. Nucleosomes appear in
a positioned array over several hundred base pairs. In both HS2
and HS4 the NF-E2 and tandem GATA sites are located near the
5′ boundary of the region of open chromatin structure. Perhaps
most significantly, while protein binding sites are present over
several hundred base pairs near each HS, the central region of
DNase I-sensitive chromatin structure closely corresponds to the
functional core region of HS2 when analyzed for its ability to
direct copy number-dependent expression in transgenic mice and
high level expression in MEL cells (16,33). Also shown is the
region where the binding of proteins has been characterized (16).
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Figure 3. Formation of HS2 following mutation of NF-E2 and GATA binding
sites. Several DNase I HSs are formed within each construct. These include
HS2, the test HS in these experiments, 1 HS3, 2 HS3 and the neoR-associated
HS, the positive controls for these experiments. The expected location of HS2
is shown by the open arrow. The probe is the 318 bp KpnI–SacI fragment from
the 5′-end of HS2. P, parental band, XhoI–SalI fragment from the p∆HS2
plasmid (Fig. 1); M, molecular weight markers; a mixture of HindIII-digested
λ DNA and HaeIII-digested φX174 DNA.

Figure 4. Formation of HS3 following mutation of individual NF-E2 and
GATA binding sites. Several DNase I HSs are formed within each construct.
These include 1 HS3, the test HS in these experiments, and 2 HS3, HS4 and
the neoR-associated HS, the positive controls for these experiments. The
expected location of HS3 is shown by the open arrow. The probe is the 634 bp
SacI–SacI fragment from the 5′-end of HS4 (Fig. 1). P, parental band,
XhoI–XhoI fragment from the p∆HS3 plasmid (Fig. 1); M, molecular weight
markers as described in Figure 3.

When a similar analysis is applied to HS3 we see a different
picture (Fig. 6B). We have previously shown that the 1.9 kb
HindIII fragment contains three distinct DNase I HSs (14,17).
The originally identified HS3 (1 HS3) is found at the 3′-end of
this fragment and is actually composed of two HSs. The
characteristic ‘super’ or ‘major’ DNase I HS is flanked by a less
intense HS at its 5′ boundary (blots in Fig. 4). Also contained in
this HS3 fragment is another less intense DNase I HS which we
have referred to as 2 HS3. This HS is located near the 5′
boundary of the fragment. Mapping of the locations of the 1 HS3
HS bands is shown in Figure 6B. Here the parental band is the
1.9 kb HindIII HS3 fragment. The locations of the two 1 HS3
HSs are indicated by brackets. The locations of these individual
DNase I HSs are also shown schematically in Figure 6B. Because
2 HS3 is located near the 3′-end of the HindIII fragment it was
not visualized in this experiment. The location of the HS was
therefore determined by analysis of blots from Figure 4.
Nucleosomal mapping studies of the HS3 region show a more
complex pattern than was seen for HSs 2 or 4. This analysis shows
three relatively intense bands. The most 3′ band, located at the top
of the blot, corresponds to the position of maximal DNase I
sensitivity. As for HS2, the maximal MNase bands do not
correspond to the maximal DNase I HS area. The mapping of
nucleosomes in the HS3 region is also shown schematically in
Figure 6B. While these results indicate a more extensive pattern
of nucleosome disruption and a more complex underlying
chromatin structure than is seen for HSs 2 and 4, the 1 HS3

region again closely corresponds to the minimal functional core
as determined by Grosveld and colleagues in transgenic mice
(17,34). The DNase I HS also lies near the center of the recently
characterized region of phylogenetic footprinting and associated
in vitro protein binding sites (protein binding cluster, Fig. 6B)
which extends over 1400 bp and includes ∼90 DNA–protein
interaction sites (35).
DISCUSSION
Our experiments were designed to test the hypothesis that the
NF-E2 and tandem, inverted GATA binding elements found in
each β-globin LCR HS core region are necessary for the
formation of the HSs. Our results indicate that, just as for HS4,
mutation of these sites within HS2 and HS3 causes a marked
reduction in the DNase I sensitivity of the HSs. These changes are
most dramatic when both the NF-E2 and GATA binding motifs are
mutated. Our results support the conclusion that the evolutionarily
conserved NF-E2 and tandem inverted GATA sites found in each
of the human LCR functional core regions play a critical and
similar role in the formation of the individual HSs.
The relationship between β-globin LCR chromatin
structure and function
Our experiments are based on the idea that the combination of an
NF-E2 site and tandem, inverted GATA sites comprises a
conserved element which is necessary for establishing the normal
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Philipsen and colleagues found that a 98 bp fragment of HS3
extending from the 5′ set of tandem GATA sites through the 3′ set
of tandem GATA sites was able to confer copy number-dependent
expression in transgenic mice. These are the same sites mutated
in the current study. Deletion of either of these sets of tandem
GATA sites from their test construct resulted in markedly
decreased expression and loss of copy number dependence (32).
Specific mutation of the tandem NF-E2 elements of HS2 resulted
in a 4-fold decrease in average expression when assayed as stable
integrants in MEL cells (17). Mutation of these sites in transient
assays results in the complete loss of HS2 enhancer activity (29).
Deletion of the tandem NF-E2 sites in the context of a 1.9 kb HS2
fragment in transgenic mice resulted in a 20-fold decrease in
expression levels but copy number dependence was maintained
(33). Taken together, these results indicate that the specific NF-E2
and tandem GATA sites we have studied in HSs 2, 3 and 4 are not
only required for the formation of the native chromatin structures
of the HSs, but are also important for the functional activities of
the LCR.
Mechanism of LCR HS formation

Figure 5. Formation of HS3 following mutation of multiple factor binding sites.
DNase I HSs include 1 HS3, the test HS in these experiments, and 2 HS3,
HS4 and the neoR-associated HS, the positive controls for these experiments.
The expected location of HS3 is shown by the open arrow. HS4 is obscured in
mutants H3M6 and H3M7 by the presence of an artifactual band. This band is
present in the ‘0’ DNase I lane and does not change with increasing DNase I
concentration. The probe is the 634 bp SacI–SacI fragment from the 5′-end of
HS4. P, parental band, XhoI fragment from the p∆HS3 plasmid (Fig. 1); M,
molecular weight markers as described in Figure 3.

chromatin structure of the active elements of the LCR. A related
hypothesis is that the formation of the LCR HS structures is
necessary for LCR function. Since the initial description of the
β-globin LCR, studies of LCR function have been performed in
a variety of experimental contexts. If formation of HS chromatin
structures is necessary for LCR function, then these studies
should demonstrate the importance of the same NF-E2 and GATA
binding sites in LCR function. Studies aimed at defining the
minimal LCR elements necessary for high level and positionindependent expression of linked globin genes have been
performed for HSs 2, 3 and 4. As shown in Figure 6, these
minimal elements correspond closely to the open chromatin
domains of HS2 and HS3 and contain the NF-E2 and GATA
binding sequences (16,17,33,34). Similar results were found for
HS4 (15). One exception to this conclusion is that the ‘minimal’
core of HS3, as defined by Philipsen et al., does not encompass
the NF-E2 site of HS3 (17). However, while this core region is
able to direct copy number-dependent expression in multi-copy
transgenic mice, gene expression levels are only ∼50% of those
observed with the full 1.9 kb HindIII HS3 fragment. Also, the
NF-E2 site is footprinted in vivo (36) and is conserved between
species (14,35). In vivo footprinting of the HS3 region also shows
binding to both tandem GATA motifs (36). The same study also
demonstrated in vivo binding to the tandem GATA element of HS2.
Functional studies examining the effects of mutating individual
binding sites within HS2 and HS3 have also been performed.

Numerous studies have shown that the DNase I HSs associated
with the β-globin LCR are erythroid specific (5–7). Other studies
have shown that the initial formation of the HSs may occur very
early in erythroid differentiation or even prior to the onset of
erythroid differentiation (37,38). Our own experiments, as well
as those of Boyes and Felsenfeld on the formation of the chicken
β-globin enhancer HS, show that even after NF-E2 and GATA
sites are mutated, a very weak HS often persists (14,20). These
investigators used a quantitative restriction endonuclease assay of
HS formation to show that the weak HS which forms in the
absence of NF-E2 and/or GATA sites is due to a decrease in the
proportion of HS regions which, within a cell population, are in
a DNase I-hypersensitive conformation (20). Thus, binding of as
yet unspecified factors may result in the initial remodeling of a
small proportion of HS regions. The subsequent binding of
NF-E2 and GATA factors would then stabilize this structure and
shift the equilibrium from the nuclease-insensitive to the
nuclease-sensitive conformations of the HS. Supporting this
model are recent unpublished results from our laboratory
suggesting that the NF-E2 and tandem, inverted GATA sites are,
on their own, insufficient for HS formation in nuclear chromatin.
While we have largely focused on the cis-acting sequences
necessary for LCR HS formation, the trans-acting factors which
mediate these structural changes are also relevant. In MEL cells,
GATA-1 is the only readily detectable GATA family member
(39,40). This implies that GATA-1 is able to mediate HS
formation. Other GATA proteins such as GATA-2, which is
expressed earlier in erythroid differentiation, may also be able to
participate in LCR HS formation (41). NF-E2 and, to a lesser
extent, AP-1 comprise the NF-E2 consensus sequence binding
activity in MEL cells (42). Mutation of DNA bases required for
NF-E2 binding, but not for AP-1 binding, within the HS4 core
resulted in decreased DNase I sensitivity (14). These results
suggest that NF-E2 is also a necessary trans-acting factor for full
LCR HS formation. Supporting this conclusion are experiments
performed by Armstrong and Emerson in a cell-free system,
which demonstrated the ability of NF-E2 to disrupt local
nucleosomal structure, and by Gong et al., which showed that the
tandem NF-E2 sites of HS2 were necessary for HS formation on
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Figure 6. Local chromatin structure of LCR HS2 and HS3. (A) DNase I and MNase analysis of HS2. Here the parental band (P) is the 1.45 kb KpnI–BglII HS2 fragment.
The probe is the 318 bp KpnI–SacI fragment from the 5′-end of HS2. (B) DNase I and MNase analysis of HS3. The parental band (P) is the 1.9 kb HindIII HS3 fragment.
The probe is the 259 bp HindIII–SacI fragment from the 5′-end of HS3. For DNase I experiments the regions of preferential cutting are indicated by brackets. HS DNase I
and MNase mapping studies are summarized showing areas of DNase I sensitivity (open boxes) and nucleosomal location as determined by MNase digestion (circles).
Mapping was performed as described in Materials and Methods. Also shown are the locations of the NF-E2 (N) and tandem GATA (G) binding elements, the functional
core elements of the HSs and previously characterized regions of protein binding. M (over gel), molecular weight markers as described in Figure 3. M with bracket
on the nucleosome figure indicates the site of maximal MNase digestion.

an Epstein–Barr-derived minichromosome in K562 cells (43,44).
MEL cells lacking NF-E2 have been shown to form LCR HSs
(45). However, our results and those of the Felsenfeld laboratory
predict that the loss of NF-E2 would not abolish the HS, but
would result only in a decrease in its DNase I sensitivity (14,20).
Factors interacting with the tandem GATA binding elements
appear to play a special role in LCR HS formation. For example,
while ∼90 in vitro DNA–protein interactions have been identified
within or near the HS3 core region (35), the mutation of only the
3′ set of tandem GATA sites results in the near complete loss of
the HS. Similar results were seen in our studies of HSs 2 and 4.
The apposition of the tandem, inverted GATA binding elements
may result in a unique interaction between GATA binding
proteins which stabilizes the chromatin structure of the HS. This
potential structural role of GATA proteins is distinct from their
previously described transcriptional functions (46) and raises the
possibility that one of the key functions of GATA-1 may be the

maintenance of an open or active chromatin structure surrounding
erythroid-specific gene loci.
The active elements of the LCR have several features in
common (i.e. they are contained within developmentally stable,
erythroid-specific DNase I HSs, they confer copy numberdependent expression in multi-copy transgenic mice and they are
evolutionarily conserved). Despite these functional similarities,
little structural similarity has been found between the HSs, other
than the observation that they contain clusters of similar DNA
binding factors (47,48). Our finding of evolutionarily conserved,
similarly arranged NF-E2 and GATA binding elements within
HSs 2, 3 and 4 which appear to serve the common function of
tissue-specific local chromatin structure reorganization raises two
possibilities. The first is that the active elements of the LCR may
be related by more than just the fact that they contain clusters of
similar trans-factor binding sites. A common, multi-protein
structure may be formed at the center of each LCR element.
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Potential functions of this structure include mediating interactions
between individual HS elements (as in the holocomplex model of
LCR function) or between the HS elements and distant globin
gene promoters. Another potential function of the common
structure might be to open local chromatin to allow assembly of
the full complement of DNA binding factors necessary for LCR
function. Our findings also raise the possibility that the LCR HSs
may share a common evolutionary heritage. Just as the individual
globin genes arose by gene duplication and subsequent divergence,
the LCR HSs may also have arisen from a common ‘ancestor’
regulatory element, followed by evolutionary divergence of
protein binding sites around the central core region, leading to
different functional roles for each HS.
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